Home / Inspections / 1018347

FDA Inspection 1018347 — Novartis Pharma Schweizerhalle Ag

Novartis Pharma Schweizerhalle Ag — FEI 3002865753

The FDA completed an inspection of Novartis Pharma Schweizerhalle Ag on June 23, 2017 in Pratteln. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 23, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pratteln (Switzerland)

Facility

Other inspections at this facility

  • 1289844 (VAI Thu Mar 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180967 (NAI Thu Aug 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 938183 (NAI Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 810431 (NAI Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 672696 (VAI Fri Jul 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources